Symbol="ACOR"
AssetType="Common Stock"
Name="Acorda Therapeutics Inc"
Description="Acorda Therapeutics, Inc., a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company is headquartered in Ardsley, New York."
CIK="1008848"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="420 SAW MILL RIVER ROAD, ARDSLEY, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="20565300"
EBITDA="9540000"
PERatio="None"
PEGRatio="0.51"
BookValue="54.64"
DividendPerShare="0"
DividendYield="0"
EPS="-40.53"
RevenuePerShareTTM="94.26"
ProfitMargin="-0.179"
OperatingMarginTTM="-0.188"
ReturnOnAssetsTTM="-0.0357"
ReturnOnEquityTTM="-0.269"
RevenueTTM="116914000"
GrossProfitTTM="82430000"
DilutedEPSTTM="-40.53"
QuarterlyEarningsGrowthYOY="5.87"
QuarterlyRevenueGrowthYOY="-0.044"
AnalystTargetPrice="10"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.108"
PriceToBookRatio="0.168"
EVToRevenue="1.497"
EVToEBITDA="-14.7"
Beta="1.432"
num_52WeekHigh="24.8"
num_52WeekLow="5.22"
num_50DayMovingAverage="14.31"
num_200DayMovingAverage="14.11"
SharesOutstanding="1216900"
DividendDate="2021-01-04"
ExDividendDate="None"
symbol="ACOR"
open="16.96"
high="17.07"
low="16.30"
price="16.90"
volume="4700.00"
latest_trading_day="2023-08-18"
previous_close="16.90"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="65"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="536413"
Change_recent_avg="0.15"
Delta_recent_avg="0.66"
Variance_recent_avg="0.33"
Change_ratio_recent_avg="1.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="1124"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0157.jpeg"
image_negative_thumbnail_id_2="1159"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0193.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="684"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0024.jpeg"
image_positive_thumbnail_id_2="601"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0107.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
